Card image cap

Susan Wild's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. House (PA) - District 7

Date Title
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
10/31/2021 Letter to Hon. Nancy Pelosi, Speaker of the House, and Hon. Steny Hoyer, House Majority Leader - Frontline Democrats Press House Leadership to Include Prescription Drugs Provisions in Build Back Better Act
08/26/2021 Letter to Bryan Cutler, Pennsylvania Speaker of the House; Kerry Benninghoff, Pennsylvania House Majority Leader; Joanna McClinton, Pennsylvania House Minority Leader; Jake Corman, Pennsylvania Senate President Pro Tempore; Kim Ward, Pennsylvania Senate Majority Leader; and Jay Costa, Pennsylvania Senate Minority Leader - Congresswoman Madeleine Dean leads a letter to Extend the Opioid Disaster Declaration
05/06/2021 Letter to the Hon. Janet Yellen, Secretary of the Treasury - Mckinley, Spanberger, Trone Urge Treasury Department to Allow States & Localities to Use American Rescue Plan Funding to Combat Opioid Epidemic
03/28/2019 Letter to Chairwoman Rosa DeLauro and Ranking Member Tom Cole - Congressman Rose Leads Push to Increase Funding for Opioid Treatment, Prevention Efforts
01/09/2019 Letter to the Hon. Nancy Pelosi, Speaker of the House, and the Hon. Steny Hoyer, House Majority Leader - Blunt Rochester Calls on House Leadership to Commit Additional Resources to Opioid & Addiction Treatment in the 116th Congress
01/09/2019 Letter to the Hon. Nancy Pelosi and the Hon. Steny Hoyer - Make Opioid Treatment a Top Priority Next Congress
arrow_upward